US Patent Issued to GENZYME on Nov. 3 for "Modified binding polypeptides for optimized drug conjugation" (French, American Inventors)

ALEXANDRIA, Va., Nov. 3 -- United States Patent no. 12,779,043, issued on Nov. 3, was assigned to GENZYME Corp. (Cambridge, Mass.).

"Modified binding polypeptides for optimized drug conjugation" was invented by Qun Zhou (Cambridge, Mass.), Sunghae Park (Cambridge, Mass.), Huawei Qiu (Cambridge, Mass.), Marie-Priscille Brun (Paris) and Francis Duffieux (Paris).

According to the abstract* released by the U.S. Patent & Trademark Office: "Engineered antibodies that are stable and can be conjugated to a ligand or drug at a ligand/drug to antibody ratio of above 3, making these conjugates suitable for treatment of a variety of indications, are provided. Methods of producing these engineered antibodies are also provided."

The patent was filed o...